Invented by Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Sederma SA

Albizia julibrissin, commonly known as the Persian silk tree, is a plant native to Asia that has been used in traditional medicine for centuries. Recently, there has been growing interest in the cosmetic use of an Albizia julibrissin extract and corresponding topical composition.

The extract from the bark of the Albizia julibrissin tree contains compounds that have been shown to have anti-inflammatory and antioxidant properties. These properties make it an attractive ingredient for use in skincare products, as they can help to reduce inflammation and protect the skin from damage caused by free radicals.

In addition to its anti-inflammatory and antioxidant properties, the Albizia julibrissin extract has also been shown to have a brightening effect on the skin. This is due to its ability to inhibit the production of melanin, which is responsible for dark spots and uneven skin tone.

The market for cosmetic products containing Albizia julibrissin extract is growing rapidly, as consumers become more aware of the benefits of natural ingredients in skincare. These products are available in a variety of forms, including serums, creams, and masks.

One of the key advantages of using Albizia julibrissin extract in skincare products is that it is suitable for all skin types. It is gentle enough for sensitive skin, yet effective enough to provide visible results for those with more mature or damaged skin.

Another advantage of using Albizia julibrissin extract in skincare products is that it is a sustainable and eco-friendly ingredient. The Albizia julibrissin tree is fast-growing and requires minimal water and fertilizer, making it an environmentally responsible choice for cosmetic manufacturers.

Overall, the market for cosmetic products containing Albizia julibrissin extract is expected to continue to grow in the coming years. As consumers become more conscious of the ingredients in their skincare products, natural and sustainable ingredients like Albizia julibrissin extract will become increasingly popular.

The Sederma SA invention works as follows

The present invention proposes a cosmetic treatment for skin glycation using an extract of Albizia jubrissin. The extract is obtained preferably from seeds or flowers. Cosmetic formulations are used to treat cutaneous fatigue and improve the skin’s radiance, eye contour (under-eye bags and dark circles), and skin suppleness. “A preferred composition for eye contour is Albizia Julibrissin combined with Darutoside, which can be obtained from Siegesbeckia orientalis.

Background for Cosmetic Use of an Albizia julibrissin Extract and Corresponding Topical Composition

Composition Preparation

The expression “physiologically acceptible medium” means according to the present invention, without limitation, an aqueous or hydroalcoholic solution, a water-in-oil emulsion (or oil-inwater emulsion), a microemulsion (or micro-emulsion), an ionic gel (or anhydrous gel), saline, vesicles dispersed in vesicles or powder. According to the present invention “the expression?physiologically acceptable medium?

?Physiologically acceptable? “?Physiologically acceptable?

This?physiologically acceptible medium? “This?physiologically acceptable medium? forms what is commonly referred to as the excipient or composition.

The dosage of Albizia Julibrissin or Darutoside, if present in the extract, is dependent on a number of factors, including the patient’s age, skin condition, severity of disorder, and mode of administration. Effective amount is a non-toxic amount sufficient to achieve the desired result.

According to the invention, for the anti-glycation use and eye contour, the Albizia Julibrissin or Darutoside extract, if present, must be present in a sufficient amount. This amount is usually between 0.00001% and 90%, but more specifically from 0.0001% up to 25% and, furthermore, from 0.001% up to 10%, based on total weight of composition. A person with knowledge of the art can adjust the amount to achieve the desired result.

The excipient is chosen according to the limitations of the Albizia Julibrissin or Darutoside material (stability, soluble, etc.). If necessary, the excipient is chosen according to the desired dosage form for the composition.

The Albizia Julibrissin and Darutoside, if present, may be incorporated in a composition using an aqueous solvent, or dissolved with the usual physiologically accepted solubilizers. For example, and without limitation to this list, these include: ethanol propanol isopropanol propylene glycol glycerin butylene glycol polyethylene glycol. You can also try emulsifiers to dissolve the extract. “A powder medium can be used.

The compositions that are adapted to the present invention can be prepared using conventional methods, which any person skilled in the art will recognize. These include the preparation of topical and orally administered compositions as well as injection compositions. These methods can involve mixing ingredients in one or several steps to achieve a uniform state. This may be done with or without heating or cooling.

The invention includes all galenic forms, i.e. Creams and lotions; ointments and gels; emulsions and dispersions; solutions and suspensions. Cleansers and foundations. Deodorants, nose sprays, etc. These compositions can also take the form of lipsticks that are intended to either color or prevent chapping on the lips, or eye-shadows, foundations, and makeup for the eyes. Compositions of the invention may include cosmetics, pharmaceuticals and personal care products. Compositions in the form or aerosol compositions, which also contain a propellant under pressure, can be considered. Compositions of the invention may also be used for oral purposes, such as toothpaste. The compositions can contain additives and adjuvants that are conventional in compositions for oral usage, such as surfactants and thickening agents. They may also include polishing agents like silica and various active ingredients, such as sodium fluoride and other fluorides.

The Albizia Julibrissin and Darutoside extracts if present in accordance with the present invention can be in the form or solution, dispersion or emulsion or paste or powder. They may also be vehicled in the forms of macro-micro-or nanospheres, liposomes oleosomes chylomicrons macro-micro-or nanoparticles macro-micro-or nanosponges or micro-or nanoemulsions.

The Albizia Julibrissin Extract and Darutoside, if present, according to the invention, may be used, in any form, bound to, incorporated into, absorbed in, or adsorbed onto macro- or micro-particles or nanocapsules for the treatment and care of textiles and natural or synthetic fibers. This includes wools and other materials used to make clothing, underwear, day and night clothes, handkerchiefs and cloths that are intended to be in contact with skin

Cosmetic treatment method

The present invention proposes also a cosmetic topical treatment to treat glycation in skin proteins, which comprises topically applying a composition containing an Albizia Julibrissin, as recited, to the subject’s skin.

?Topical treatment? “Topical treatment” means a product that acts where it is applied, such as on the skin, mucosa or skin appendages.

The invention provides a method that is specifically adapted for:

The method is adapted for tired skin and especially the eye contour thanks to its synergetic effect on dark circles, under-eye bags, wrinkles, and fine lines, and on the eyelids.

Topical application can improve the appearance and condition of skin, mucous membranes and appendages by applying it regularly, such as every day.

The practitioner will be able to appreciate a topical cosmetic treatment containing an Albizia Julibrissin Extract. This treatment can be achieved, for example, by applying topically, the composition described in this invention, using a standard method of application. The topical composition can be applied daily for at least one week but may also be applied over a period of 2, 4, 8, or 12 weeks. The topical composition can be used on any part of the body that requires aesthetic improvement. It is most commonly applied to the neck and face, but it may also be applied anywhere else. The European standard dosage for cosmetic face treatments is 2.72mg/cm2/day/person.

The terms “treating” and “treatment” are used to refer to the reduction, improvement and/or elimination, of dermatological effects including aging. The compositions and methods of the present invention are suitable to be used for treating skin conditions in various areas of skin including, without limitation, face, forehead lips, neck, neckline and arms, hands and body.

Click here to view the patent on Google Patents.